SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANRG -- Anergen -- new CEO big chance ?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LightPen who wrote (48)10/19/1997 7:28:00 PM
From: LightPen   of 123
 
I think this may be the venue and time

Day: Sunday, November 09, 1997
Time: 12:30 Room: Hall B
Type: ACR Poster Session
Session: Rheumatoid Arthritis - Treatment II

Time: 12:30 Program number: 393
Title: Vaccination of rheumatoid arthritis patients with
DR4/1-peptide.
Authors: St. Clair E.W.; Cohen S.B.; Fleischmann R.M.; Lee S.;
Moreland L.; Olsen N.J.; Pratt P.W.; Yocum D.E.; Winkelhake J.;
Holcenberg J.; Shulman M.G.;
Affiliation: Dallas, TX; Nashville, TN; Dothan, AL; Tucson, AZ and
Durham, NC
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News